Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

VISTN.OL

STRONG BUY

Vistin Pharma ASA · Healthcare · Norway · $93M · Avg Vol: $69K/d

99
StockRank
Q
83
V
61
M
62
P/E (TTM)
13.6x
ROE
21.9%
D/E
0.0x
Dividend %
9.9%
Director Trades · 180d
None in 180d →
Buybacks · 180d
None in 180d →

COMPANY DESCRIPTION

Vistin Pharma ASA is a Norwegian pharmaceutical company and a leading global producer of Metformin Active Pharmaceutical Ingredient (API), used in diabetes treatment. The company operates a highly automated, state-of-the-art manufacturing facility in Norway, serving global pharmaceutical giants. Its competitive advantage is driven by high-quality standards, cost-efficient production, and long-term supply agreements in a growing global market.

Loading...
PRICE (1Y)-9.0%
2.102.162.232.302.36May 8Jun 2Jun 22
SMA 50SMA 200
Close
$2.10
RSI (14)
42.3
52W High
$2.49
From 52W High
0.8%

SCORE BREAKDOWN

Quality
83
ROIC
27.7%95.8
ROE
21.9%90.1
GP/Assets
68.1%93.1
Op. Margin
19.2%81.1
FCF/Assets
3.8%65.0
Piotroski
375.1
Int. Cover
49.9x76.7
D/E Ratio
0.00x96.9
Current Ratio
2.96x52.9
Value
61
P/E (TTM)
13.6x77.0
EV/EBITDA
9.0x72.6
P/FCF
502.9x18.0
P/B
3.1x41.6
P/S
2.2x64.0
Div Yield
9.9%98.7
Momentum
62
52W High %
84%86.6
RS 6M
-18%74.5
SMA 50/200
1.02x64.6
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
-1%39.2

FUNDAMENTALS

Market Cap
$93M
P/E (Forward)
—
Gross Margin
66.6%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of VISTN.OL are excluded.

TickerCompanyMkt CapStockRankSignal
VISTN.OLVistin Pharma ASA(you)$93M99STRONG BUY
PHO.OLPhotocure ASA$166M70BUY
MEDI.OLMedistim ASA$438M86STRONG BUY
NYKD.OLNykode Therapeutics AS$109M46HOLD
AZT.OLArcticZymes Technologies ASA$107M45HOLD
TRMED.OLThor Medical ASA$157M20SELL
ZLNA.OLZelluna ASA$51M20SELL
CRNA.OLCircio Holding ASA$232M20SELL

Peer medians: ROE 4.1% · P/E 26.9x · Gross margin 93.6%

Vistin Pharma ASA (VISTN.OL) — Stock Score Summary

Vistin Pharma ASA (VISTN.OL) has a MoatMap StockRank of 99/100 based on Quality (83/100), Value (61/100), and Momentum (62/100) factor scores. The current signal is STRONG BUY.

Vistin Pharma ASA is a Norwegian pharmaceutical company and a leading global producer of Metformin Active Pharmaceutical Ingredient (API), used in diabetes treatment. The company operates a highly automated, state-of-the-art manufacturing facility in Norway, serving global pharmaceutical giants. Its competitive advantage is driven by high-quality standards, cost-efficient production, and long-term supply agreements in a growing global market.

Key Financial Metrics

Price$2.10
Market Cap$93M
P/E (TTM)13.57
Price/Book3.07
Return on Equity21.9%
Return on Invested Capital27.7%
Debt/Equity0.14
Gross Margin66.6%
Operating Margin19.2%
Revenue Growth-2.5%
Dividend Yield9.9%
Free Cash Flow$185K

Vistin Pharma ASA operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (Norway).

Frequently Asked Questions

What is Vistin Pharma ASA’s (VISTN.OL) StockRank?
MoatMap’s StockRank for Vistin Pharma ASA (VISTN.OL) is 99/100, with a Strong Buy signal. It is a composite of Quality (83), Value (61), and Momentum (62) factor ranks across MoatMap’s 20,000+ stock universe.
Does Vistin Pharma ASA have an economic moat?
Vistin Pharma ASA (VISTN.OL) has a Quality factor score of 83/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Vistin Pharma ASA a buy, hold, or sell?
MoatMap’s current signal for Vistin Pharma ASA (VISTN.OL) is Strong Buy, based on a StockRank of 99/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Vistin Pharma ASA in?
Vistin Pharma ASA (VISTN.OL) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (Norway).
Browse all ranked stocksVISTN.OL deep dive reportAI ChampionsHow we score stocksSense-check another stock